Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Polychlorinated dibenzo-p-dioxins (PCDDs) and dibenzofurans (PCDFs) soil contamination in Lausanne, Switzerland: Combining pollution mapping and human exposure assessment for targeted risk management.
Vernez D, Oltramare C, Sauvaget B, Demougeot-Renard H, Aicher L, Roth N, Rossi I, Radaelli A, Lerch S, Marolf V, Berthet A. Vernez D, et al. Among authors: aicher l. Environ Pollut. 2023 Jan 1;316(Pt 1):120441. doi: 10.1016/j.envpol.2022.120441. Epub 2022 Oct 29. Environ Pollut. 2023. PMID: 36349640 Free article.
The signature of a T-cell response to KSHV persists across space and time in individuals with epidemic and endemic KS from Uganda.
Ravishankar S, Towlerton AMH, Mooka P, Kafeero J, Coffey DG, Aicher LD, Mubiru KR, Okoche L, Atwinirembabazi P, Okonye J, Phipps WT, Warren EH. Ravishankar S, et al. Among authors: aicher ld. bioRxiv [Preprint]. 2024 Feb 8:2024.02.06.579223. doi: 10.1101/2024.02.06.579223. bioRxiv. 2024. PMID: 38370623 Free PMC article. Preprint.
Mavorixafor, an Orally Bioavailable CXCR4 Antagonist, Increases Immune Cell Infiltration and Inflammatory Status of Tumor Microenvironment in Patients with Melanoma.
Andtbacka RHI, Wang Y, Pierce RH, Campbell JS, Yushak M, Milhem M, Ross M, Niland K, Arbeit RD, Parasuraman S, Bickley K, Yeung CC, Aicher LD, Smythe KS, Gan L. Andtbacka RHI, et al. Among authors: aicher ld. Cancer Res Commun. 2022 Aug 31;2(8):904-913. doi: 10.1158/2767-9764.CRC-22-0090. eCollection 2022 Aug. Cancer Res Commun. 2022. PMID: 36923305 Free PMC article. Clinical Trial.
A Phase 1/2 Trial Combining Avelumab and Trabectedin for Advanced Liposarcoma and Leiomyosarcoma.
Wagner MJ, Zhang Y, Cranmer LD, Loggers ET, Black G, McDonnell S, Maxwell S, Johnson R, Moore R, Hermida de Viveiros P, Aicher L, Smythe KS, He Q, Jones RL, Pollack SM. Wagner MJ, et al. Among authors: aicher l. Clin Cancer Res. 2022 Jun 1;28(11):2306-2312. doi: 10.1158/1078-0432.CCR-22-0240. Clin Cancer Res. 2022. PMID: 35349638 Free PMC article. Clinical Trial.
Insights into possibilities for grouping and read-across for nanomaterials in EU chemicals legislation.
Mech A, Rasmussen K, Jantunen P, Aicher L, Alessandrelli M, Bernauer U, Bleeker EAJ, Bouillard J, Di Prospero Fanghella P, Draisci R, Dusinska M, Encheva G, Flament G, Haase A, Handzhiyski Y, Herzberg F, Huwyler J, Jacobsen NR, Jeliazkov V, Jeliazkova N, Nymark P, Grafström R, Oomen AG, Polci ML, Riebeling C, Sandström J, Shivachev B, Stateva S, Tanasescu S, Tsekovska R, Wallin H, Wilks MF, Zellmer S, Apostolova MD. Mech A, et al. Among authors: aicher l. Nanotoxicology. 2019 Feb;13(1):119-141. doi: 10.1080/17435390.2018.1513092. Epub 2018 Sep 5. Nanotoxicology. 2019. PMID: 30182766 Review.
Scientific Basis for Regulatory Decision-Making of Nanomaterials Report on the Workshop, 20-21 January 2014, Center of Applied Ecotoxicology, Dübendorf.
Studer C, Aicher L, Gasic B, von Goetz N, Hoet P, Huwyler J, Kägi R, Kase R, Kobe A, Nowack B, Rothen-Rutishauser B, Schirmer K, Schneider G, Vermeissen E, Wick P, Walser T. Studer C, et al. Among authors: aicher l. Chimia (Aarau). 2015;69(1-2):52-6. doi: 10.2533/chimia.2015.52. Chimia (Aarau). 2015. PMID: 26507088 Free article.
42 results